Literature DB >> 7887426

Deletion and translocation of chromosome 11q13 sequences in cervical carcinoma cell lines.

R A Jesudasan1, R A Rahman, S Chandrashekharappa, G A Evans, E S Srivatsan.   

Abstract

Molecular genetic studies on HeLa cell-derived nontumorigenic and tumorigenic hybrids have previously localized the HeLa cell tumor-suppressor gene to the long arm of chromosome 11. Extensive molecular and cytogenetic studies on HeLa cells have shown chromosome band 11q13 to be rearranged in this cell line. To determine whether q13 rearrangement is a nonrandom event in cervical carcinomas, six different human papilloma virus (HPV)-positive (HeLa, SiHa, Caski, C4-I, Me180, and Ms751) and two different HPV-negative (C33A and HT3) cell lines were studied. Long-range restriction mapping using a number of q13-specific probes showed molecular rearrangements within 75 kb of INT2 probe in three HPV-positive cell lines (HeLa, SiHa, and Caski) and in an HPV-negative cell line (HT3). FISH using an INT2 YAC identified a breakpoint within the sequences spanned by this YAC in two of the cell lines, HeLa and Caski. INT2 cosmid derived from this YAC showed deletion of cosmid sequences in two other cell lines, SiHa and C33A. These two cell lines, however, retained cosmid sequences of Cyclin D1, a probe localized 100 kb proximal to INT2. Deletions being the hallmark of a tumor-suppressor gene, we conclude that the 100-kb interval between the two cosmids might contain sequences of the cervical carcinoma tumor-suppressor gene.

Entities:  

Mesh:

Year:  1995        PMID: 7887426      PMCID: PMC1801173     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  28 in total

Review 1.  Human papillomaviruses and genital cancer.

Authors:  H Pfister
Journal:  Adv Cancer Res       Date:  1987       Impact factor: 6.242

2.  Hereditary cancer, oncogenes, and antioncogenes.

Authors:  A G Knudson
Journal:  Cancer Res       Date:  1985-04       Impact factor: 12.701

3.  Somatic deletions and mutations of c-Ha-ras gene in human cervical cancers.

Authors:  G Riou; M Barrois; Z M Sheng; P Duvillard; C Lhomme
Journal:  Oncogene       Date:  1988-09       Impact factor: 9.867

4.  Human papillomavirus types 16 and 18 sequences in early cervical neoplasia.

Authors:  M M Pater; J Dunne; G Hogan; P Ghatage; A Pater
Journal:  Virology       Date:  1986-11       Impact factor: 3.616

5.  High correlation between molecular alterations of the c-myc oncogene and carcinoma of the uterine cervix.

Authors:  R Ocadiz; R Sauceda; M Cruz; A M Graef; P Gariglio
Journal:  Cancer Res       Date:  1987-08-01       Impact factor: 12.701

6.  Cellular differentiation, cytidine analogs and DNA methylation.

Authors:  P A Jones; S M Taylor
Journal:  Cell       Date:  1980-05       Impact factor: 41.582

7.  Human papillomaviruses and cervical cancer: analysis of histopathologic features associated with different viral types.

Authors:  S P Wilczynski; S Bergen; J Walker; S Y Liao; L F Pearlman
Journal:  Hum Pathol       Date:  1988-06       Impact factor: 3.466

8.  Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma.

Authors:  C Larsson; B Skogseid; K Oberg; Y Nakamura; M Nordenskjöld
Journal:  Nature       Date:  1988-03-03       Impact factor: 49.962

9.  Introduction of human chromosome 11 via microcell transfer controls tumorigenic expression of HeLa cells.

Authors:  P J Saxon; E S Srivatsan; E J Stanbridge
Journal:  EMBO J       Date:  1986-12-20       Impact factor: 11.598

10.  Selective suppression of human papillomavirus transcription in non-tumorigenic cells by 5-azacytidine.

Authors:  F Rösl; M Dürst; H zur Hausen
Journal:  EMBO J       Date:  1988-05       Impact factor: 11.598

View more
  12 in total

1.  Loss of transformed phenotype in cancer cells by overexpression of the uteroglobin gene.

Authors:  Z Zhang; G C Kundu; D Panda; A K Mandal; G Mantile-Selvaggi; A Peri; C J Yuan; A B Mukherjee
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

2.  Alterations of chromosome 11q13 in cervical carcinoma cell lines.

Authors:  N C Popescu; D B Zimonjic
Journal:  Am J Hum Genet       Date:  1996-02       Impact factor: 11.025

3.  Antioxidant-induced changes of the AP-1 transcription complex are paralleled by a selective suppression of human papillomavirus transcription.

Authors:  F Rösl; B C Das; M Lengert; K Geletneky; H zur Hausen
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

4.  Deletion in chromosome 11 and Bcl-1/Cyclin D1 alterations are independently associated with the development of uterine cervical carcinoma.

Authors:  Ratnesh Kumar Singh; Santanu Dasgupta; Nilanjana Bhattacharya; Neelanjana Chunder; Ranjit Mondal; Anup Roy; Syamsundar Mandal; Susanta Roychowdhury; Chinmay Kumar Panda
Journal:  J Cancer Res Clin Oncol       Date:  2005-03-15       Impact factor: 4.553

5.  A human homolog of the Schizosaccharomyces pombe rad9+ checkpoint control gene.

Authors:  H B Lieberman; K M Hopkins; M Nass; D Demetrick; S Davey
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

6.  Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation.

Authors:  Claudio Talora; Dennis C Sgroi; Christopher P Crum; G Paolo Dotto
Journal:  Genes Dev       Date:  2002-09-01       Impact factor: 11.361

7.  Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix.

Authors:  K Heselmeyer; E Schröck; S du Manoir; H Blegen; K Shah; R Steinbeck; G Auer; T Ried
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

8.  Inactivation of the cystatin E/M tumor suppressor gene in cervical cancer.

Authors:  Mysore S Veena; Grant Lee; Daniel Keppler; Marc S Mendonca; J Leslie Redpath; Eric J Stanbridge; Sharon P Wilczynski; Eri S Srivatsan
Journal:  Genes Chromosomes Cancer       Date:  2008-09       Impact factor: 5.006

9.  Construction of eukaryotic expression vector of human CC10 gene and expression of CC10 protein in lung adenocarcinoma A549 cell line.

Authors:  Sheng Zhong; Yongjian Xu; Zhenxiang Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

10.  Oral cancer overexpressed 1 (ORAOV1) regulates cell cycle and apoptosis in cervical cancer HeLa cells.

Authors:  Lu Jiang; Xin Zeng; Zhi Wang; Ning Ji; Yu Zhou; Xianting Liu; Qianming Chen
Journal:  Mol Cancer       Date:  2010-01-28       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.